Trial intelligence / Profile preview

Metformin for Benign Thyroid Nodules

NCT03183752Completed

Sponsor
Hospital Universitário Clementino Fraga Filho
Start
Aug 2015
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in benign thyroid nodule comparing Metformin with Placebo (2 arms). Primary endpoint: changes in nodule volume from baseline after metformin use at 1 year. Started Aug 2015; status: completed.

02

Drugs

metformin
03

Conditions

benign thyroid nodule

Beyond the preview

Go deeper on NCT03183752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03183752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call